Drug information key to NHS Evidence
This article was originally published in Scrip
Drug information and prescribing guidance will be a major part of the new NHS (National Health Service) Evidence portal to be launched in April next year, says England'sdepartment of health.
You may also be interested in...
Insurers argue that better use of real world data and multiple pricing assessments could help lower drug prices in Germany.
To keep investors happy, companies will have to start showing that their high-priced advanced therapies offset costs elsewhere in the health care system.
To maintain high prices and avoid access restrictions, companies marketing advanced therapies will have to show payers that their products save money elsewhere in the healthcare system.